Completed
Real-Life Efficacy and Safety of Nivolumab in Patients With Advanced Renal Cell Carcinoma After Prior Therapy - CA209-653
Aggiornato:
8 luglio, 2025
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice